Vaughan Nelson Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,166,741
Closed -$44M 209
2024
Q3
$44M Sell
2,166,741
-657,560
-23% -$13.4M 0.39% 86
2024
Q2
$63.7M Buy
2,824,301
+178,625
+7% +$4.68M 0.59% 46
2024
Q1
$69.5M Buy
2,645,676
+1,263,875
+91% +$36M 0.61% 42
2023
Q4
$43.6M Buy
1,381,801
+29,475
+2% +$800K 0.44% 71
2023
Q3
$37.9M Buy
1,352,326
+37,590
+3% +$1.29M 0.43% 67
2023
Q2
$48.5M Buy
1,314,736
+58,324
+5% +$1.78M 0.54% 49
2023
Q1
$37.6M Sell
1,256,412
-26,495
-2% -$873K 0.46% 62
2022
Q4
$39.3M Buy
1,282,907
+20,215
+2% +$607K 0.51% 59
2022
Q3
$31.1M Buy
1,262,692
+154,847
+14% +$5.11M 0.45% 76
2022
Q2
$35.5M Sell
1,107,845
-696,245
-39% -$25.6M 0.48% 65
2022
Q1
$56.8M Buy
1,804,090
+138,945
+8% +$4.35M 0.65% 47
2021
Q4
$55.9M Sell
1,665,145
-543,320
-25% -$16.9M 0.57% 45
2021
Q3
$64.2M Buy
2,208,465
+1,520
+0.1% +$49.2K 0.65% 43
2021
Q2
$76.8M Buy
2,206,945
+174,675
+9% +$5.78M 0.78% 38
2021
Q1
$56.7M Buy
+2,032,270
New +$54.1M 0.61% 62

Other funds holding CC

Vaughan Nelson Investment Management's CC Position: Q4 2024 in Review

Vaughan Nelson Investment Management sold out of Chemours (CC) in Q4 2024, closing a stake of 2,166,741 shares — an estimated $44M sold.

Vaughan Nelson Investment Management first reported a position in CC in Q1 2021 and held it in 15 quarters. The position peaked at $76.8M in Q2 2021. 441 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Vaughan Nelson Investment Management reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 2,166,741 Chemours shares in Q4 2024, an estimated $44M.
  • Vaughan Nelson Investment Management first reported a position in Chemours in Q1 2021 and held it in 15 quarters.
  • Vaughan Nelson Investment Management's Chemours position peaked at $76.8M in Q2 2021.
  • 441 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Vaughan Nelson Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.